RAD Virtual Conference - Sunday, December 11, 2022

Although diagnosis of Atopic Dermatitis (AD) is straightforward in children, its diagnosis is challenging in adults. Advances in research on AD epidemiology, burden and comorbidities have transformed the understanding of the course of AD, including risk factors, age of onset, disease severity and persistence, and health outcomes. Clinicians may not be aware of the epidemiology of AD for proper risk stratification, patient education and therapeutic decision-making. Atopic dermatitis is a heterogeneous disorder with variable severity of signs and symptoms, and impact on quality of life. Clinicians may not be able to assess AD severity accurately in order to optimize therapy.

Our Conference allows clinicians to understand this disease better through the latest in research, expert faculty speakers, late-breaking research and Q&A sessions.

Target Audience

This program is intended for dermatologists, allergists and immunologists, primary care clinicians, NPs/RNs/APRNs, physician assistants and other allied health professionals as well as patients/patient groups engaged in the care of patients with AD.

Educational Objectives

After completing this activity, upon diagnosis and assessment of severity of AD, the participant should be better able to:

  • Highlight burden of sleep disturbances and mental health comorbidities in AD
  • Review evidence-based approaches to addressing the mental health burden of AD
  • Discuss gaps in research and current needs from the patient and healthcare provider perspectives
  • Apply improved understanding of pathophysiology, currently available and emerging treatment options in therapeutic decision making for AD
  • Discuss different pathways of digital innovation in research and healthcare
  • Identify unmet needs and opportunities for digital innovation in AD
  • Illustrate recent innovations in digital medicine for measuring nocturnal scratch in AD

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Revolutionizing Atopic Dermatitis. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Postgraduate Institute for Medicine designates this live activity for a maximum 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The maximum number of hours awarded for this Continuing Nursing Education activity is 8.0 contact hours.


Please note that you will not receive an email confirming registration until after the fee has been paid. If you have a discount code, please enter the code when registering. Once you do so and complete the required registration information, you will receive a confirmation email.

Registration Rates - Virtual Conference

October 4 - October 31, 2022
November 1 - December 11, 2022

Physicians and Fellows

US$ 50.00

US$ 75.00

RNs, NPs, APRNs, PAs US$ 50.00 US$ 75.00
Residents and Students Free Free
Industry - Exhibits and Scientific Sessions US$ 300.00 US$ 500.00
Patients Free Free

If you are a resident, student, patient, or member of the media, and you are interested in attending the Conference, please contact Patrice Melluso: patrice@revolutionizingad.com

If you registered for the program and did not receive your registration confirmation/conference access link,
please check your spam/junk folder. If you are unable to find the email, please email Donna Jimenez: djimenez@dnadigitalgroup.com